DI.V.A.L. TOSCANA S.R.L. is a cutting edge SME engaged in providing advanced biotech solutions to academic research groups and companies operating in the field of basic Life Science research, translational biomedical research, and early stage pharmaceutical development.
The team has a long-standing scientific experience in Oncology with a focus on expression and role of hERG channels in cancer cells.
We enable our customers to characterize their products, predict human toxicity and rapidly obtain reproducible data.
We perform preclinical services for drug screening and AMP in the following areas:
- cardiac safety;
- pharmacokinetics and pharmacodynamics
All of our services (both in vivo and in vitro) are fully customizable, following the customers’ needs.
Moreover, we offer a complete range of transgenic services and we are able to generate different customized and validated disease animal models.
The company can supply high-quality polyclonal and monoclonal antibodies against ion channels and also develop customized antibodies (mAb, pAb, scFv) tailored to our customers’ needs.
Constantly involved in biomedical research, DI.V.A.L. participates in several national and international innovative projects as a SME. Our goals are:
- develop targeted theranostic systems for diagnostic and therapeutic purposes;
- develop new delivery systems for pharmaceuticals.
The long term and well documented experience of the DI.V.A.L.’s team in oncological research as well as in ion-channels-related studies has led them to have a great expertise in analyzing pharmacological compounds, developing oncological models and producing and manipulating antibodies for research purposes.
Prof. Annarosa Arcangeli
Technical and Scientific support
Dr. Massimo D'Amico
Dr. Laura Carraresi
Dr. Matteo Stefanini
Dr. Serena Pillozzi
Dr. Olivia Crociani
Prof. Marco Bazzicalupo
Orders and commercial info
Eng. Armando Casazza, CEO
Dr. Nicoletta Rossi